Registration
THORN RUN PARTNERS for OTSUKA AMERICA PHARMACEUTICAL, INC.
Firm
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical reimbursement issues. Issues related to neurological treatments. Corporate tax issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER New | Legislative Director, Rep. Tanner; Legislative Director, Rep. McIntyre |
Health Issues HCR
Pharmaceutical reimbursement issues. Issues related to neurological treatments. Corporate tax issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER New | Legislative Director, Rep. Tanner; Legislative Director, Rep. McIntyre |
Taxation/Internal Revenue Code TAX
Pharmaceutical reimbursement issues. Issues related to neurological treatments. Corporate tax issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER New | Legislative Director, Rep. Tanner; Legislative Director, Rep. McIntyre |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| OTSUKA | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.